Current evidence shows that cholesterol management either reduces the likelihood of cardiovascular disease (CVD) or slows down its progression. Hence, it is important that all health professionals make appropriate use of all the available intervention strategies to control risk factors: from dietary improvement and positive lifestyle changes to the use of functional foods, food supplements, and drugs. This review examines the effect of the most frequently occurring cholesterol-lowering substances in functional foods or in supplements across Europe, namely plant sterols and stanols, monacolin K found in red yeast rice, berberine and beta-glucans. We conclude that currently available supplements and functional foods can effectively reduce plasma LDL cholesterol levels by about 5 to 25%, either alone or in combination. Suitable candidates for these products are mainly individuals at low absolute cardiovascular risk at a young age or according to classic algorithms. Of note, despite being freely available for purchase, these products should be used following shared agreement between the physician and the patient (“concordance”).

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper / Poli, Andrea; Barbagallo, Carlo M.; Cicero, Arrigo F. G.; Corsini, Alberto; Manzato, Enzo; Trimarco, Bruno; Bernini, Franco; Visioli, Francesco; Bianchi, Alfio; Canzone, Giuseppe; Crescini, Claudio; de Kreutzenberg, Saula; Ferrara, Nicola; Gambacciani, Marco; Ghiselli, Andrea; Lubrano, Carla; Marelli, Giuseppe; Marrocco, Walter; Montemurro, Vincenzo; Parretti, Damiano; Pedretti, Roberto; Perticone, Francesco; Stella, Roberto; Marangoni, Franca. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 134:(2018), pp. 51-60. [10.1016/j.phrs.2018.05.015]

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

Lubrano, Carla
Investigation
;
2018

Abstract

Current evidence shows that cholesterol management either reduces the likelihood of cardiovascular disease (CVD) or slows down its progression. Hence, it is important that all health professionals make appropriate use of all the available intervention strategies to control risk factors: from dietary improvement and positive lifestyle changes to the use of functional foods, food supplements, and drugs. This review examines the effect of the most frequently occurring cholesterol-lowering substances in functional foods or in supplements across Europe, namely plant sterols and stanols, monacolin K found in red yeast rice, berberine and beta-glucans. We conclude that currently available supplements and functional foods can effectively reduce plasma LDL cholesterol levels by about 5 to 25%, either alone or in combination. Suitable candidates for these products are mainly individuals at low absolute cardiovascular risk at a young age or according to classic algorithms. Of note, despite being freely available for purchase, these products should be used following shared agreement between the physician and the patient (“concordance”).
2018
Cardiovascular risk; Cholesterol; Food supplements; Functional foods; LDL cholesterol; Primary prevention; Pharmacology
01 Pubblicazione su rivista::01a Articolo in rivista
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper / Poli, Andrea; Barbagallo, Carlo M.; Cicero, Arrigo F. G.; Corsini, Alberto; Manzato, Enzo; Trimarco, Bruno; Bernini, Franco; Visioli, Francesco; Bianchi, Alfio; Canzone, Giuseppe; Crescini, Claudio; de Kreutzenberg, Saula; Ferrara, Nicola; Gambacciani, Marco; Ghiselli, Andrea; Lubrano, Carla; Marelli, Giuseppe; Marrocco, Walter; Montemurro, Vincenzo; Parretti, Damiano; Pedretti, Roberto; Perticone, Francesco; Stella, Roberto; Marangoni, Franca. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 134:(2018), pp. 51-60. [10.1016/j.phrs.2018.05.015]
File allegati a questo prodotto
File Dimensione Formato  
Poli_nutraceuticals_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 593.01 kB
Formato Adobe PDF
593.01 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1118898
Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 90
social impact